Gaba A Alpha 5 Protein — Gaba A Receptor Alpha 5 Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein
|name=GABRA5
|full_name=GABA-A Receptor Alpha 5 Subunit
|gene=GABRA5
|uniprot=P31644
|pdb=6HUP
|mw=56 kDa
|location=Cell membrane, synapse
|family=Cys-loop ligand-gated ion channel family
}}
GABRA5 is a subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates inhibitory neurotransmission in the central nervous system. The alpha-5 subunit is encoded by the GABRA5 gene located on chromosome 15q12 and is predominantly expressed in the hippocampus and cortex. GABA-A receptors containing the alpha-5 subunit are extrasynaptic and mediate tonic inhibition, which is important for memory processes, spatial navigation, and emotional regulation. These receptors are implicated in cognitive disorders and are targets for cognitive enhancement and anxiolytic drugs.
GABRA5 contains:
GABRA5-containing GABA-A receptors mediate tonic inhibition:
GABRA5 is expressed in:
The study of Gaba A Alpha 5 Protein — Gaba A Receptor Alpha 5 Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Möhler et al. (2002) Nat Rev Neurosci 3:413-425
[2] Atack (2011) Adv Pharmacol 59:53-92
Last updated: 2026-03-04
The GABA-A Alpha-5 subunit (GABRA5) is enriched in the hippocampus, particularly in the CA1 region and dentate gyrus, where it contributes to hippocampal inhibitory circuits. Alpha-5 containing GABA-A receptors are primarily extrasynaptic, responding to low concentrations of GABA to generate tonic inhibition.
These receptors play a critical role in hippocampal memory circuits, modulating synaptic plasticity and network oscillations. The Alpha-5 subunit is also expressed in the cortex and olfactory bulb, contributing to sensory processing.
Alzheimer's Disease: GABRA5 expression is altered in AD, affecting hippocampal inhibitory tone. Alpha-5 receptors may be involved in the memory deficits characteristic of AD, as they play important roles in hippocampal plasticity. Some studies suggest these receptors could be therapeutic targets.
Parkinson's Disease: Alpha-5 receptors may contribute to cognitive dysfunction in PD, as the hippocampus is affected in PD-related dementia. The subunit's role in spatial memory is particularly relevant.
Huntington's Disease: GABRA5 expression is altered in HD, contributing to the characteristic motor and cognitive symptoms. The receptor may be a therapeutic target.
Inverse agonists at GABA-A Alpha-5 receptors have been explored for cognitive enhancement, as they increase hippocampal excitability and may improve memory formation. However, these compounds have shown limited efficacy and safety concerns in clinical trials.
Research focuses on understanding the role of Alpha-5 receptors in memory formation and developing safe modulators for cognitive enhancement.